Imaging or clinical markers (CT, MRI, DEXA, waist circumference, fasting insulin, HOMA-IR) provide accurate insight
Treatment plans are individualized and may include: Semaglutide (the active ingredient in Wegovy & Ozempic) and other GLP-1 medications selected based on your health profile Oral GLP-1 options for patients who are super responders or prefer to avoid injections Combination treatment strategies, including medications that support nutrient balance when using GLP-1 or metformin Long-term PCOS maintenance plans designed to help prevent weight regain after GLP-1 treatment Ongoing provider monitoring and medication management to ensure treatment remains safe and effective Your provider will help determine the safest and most effective approach based on your symptoms, metabolic health, and treatment goals
The standard protocol is 4-6 weeks on, 4-6 weeks off to maintain receptor sensitivity
This paper summarizes the neurophysiological and biological basis of hyperarousal in RLS
"Semaglutide will definitely harm your baby" Reality: There's currently no evidence of harm to breastfed infants from maternal semaglutide use
Patients will have regular follow-up visits with providers to check for side effects and update progress on their weight loss goals, Carroll said